Infections of the Posterior Segment: Cytomegalovirus Retinitis

摘要: Cytomegalovirus (CMV) retinitis remains the leading cause of visual loss in acquired immunodeficiency syndrome (AIDS) patients. The introduction highly active antiretroviral therapy (HAART) has greatly reduced incidence and prevalence ocular morbidity. Nevertheless, high suspicion comprehensive evaluation patients’ immune status is vital to provide optimum treatment limit impairment. Once clinical diagnosis been made, prompt initiation anti-CMV as well starting treatment-naive patients vital. Taking into consideration emerging drug resistance possible drug-induced toxicities, monitoring management developing complications minimize impact on final outcome.